Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Knight Therapeutics Inc
Bullboard Posts
User Avatar Image
(37)
•••
Comment by wagyusteakon May 21, 2020 11:28am
59 Views
Post# 31056303

RE:A warning to others!

RE:A warning to others!
Lookingforclues wrote:

This is not exclusively about GUD.
It is strong advice to those who look to others for direction, and the success of previous endeavours!
I did listen to Mugmod and others who were promoting J. Knight!
I read much about Paladin and its trajectory, but then cracks appeared.......
And then some people realized that he had other Private Companies, and was investing in those. Reasons for the Authorities to be aware, and to have a 'peekaboo!
And then to question someone who every day saying they were buying on dips.
And to question why Meir was unhappy.
All explainable, BUT there are just Too many obstacles!

And Yes MM I did give an alternative to GUD which was GBR.
FYI...Take a lesson from someone who nearly lost!



sure sure. just sell your shares and get out pls :)

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities